Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.
about
Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complicationsNeutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domainPassive immunity against human pathogens using bovine antibodies.Perspectives on immunoglobulins in colostrum and milkBovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestineHyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infectionNew advances in the treatment of Clostridium difficile infection (CDI)Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults.Immune-based treatment and prevention of Clostridium difficile infection.Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humansNutritional Impact of Dietary Plasma Proteins in Animals Undergoing Experimental Challenge and Implications for Patients with Inflammatory Bowel Disorders: A Meta-analysis.Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative.Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies.Stimulated enrichment of Clostridium difficile specific IgA in mature cow's milk.Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection.Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection.
P2860
Q24542134-9FCB22FC-EAEF-40AD-910B-800E697B303BQ28302768-FB06CC9A-EF5E-4218-BEF1-8B55258A1DDAQ33640433-E306527B-DEDA-41E2-BB9B-E04905951507Q34247980-D9111333-1C8F-467B-87A2-1228F54A984FQ35353994-70FEA1EE-5BF7-4EFC-90D5-7B95A6FA9213Q35661928-656B1FC2-A61A-432C-B0CC-D515519ECA3AQ37052819-0C5772FC-0388-42D6-913B-7D8BA6168C32Q37488810-E6BCDDC3-EE31-4B9D-A8A4-9BFCCF7375A6Q38350907-CDD93CC7-E111-4944-91AB-A5D2532F1770Q38423920-E8576E1D-0FCB-4D8D-9551-91BD6628F451Q38587570-09DE48D2-F9C6-450C-8E8F-4E4609FA4515Q40169068-54AEC7E5-9C75-47F9-A237-BEB58736B005Q42697422-AED5F788-1C51-4738-A6EA-85EF67008A87Q55092365-0AA54710-339E-4D94-A036-DAFF79420429Q55194285-44FF9B26-4FD1-45B5-A607-758F26E2CEB2Q55479628-13A4F618-C8EB-4D75-B578-033DBEE85DDBQ55516782-6C8829F9-2B5A-49A2-B481-0A07DD11E791
P2860
Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Survival of anti-Clostridium d ...... human gastrointestinal tract.
@ast
Survival of anti-Clostridium d ...... human gastrointestinal tract.
@en
type
label
Survival of anti-Clostridium d ...... human gastrointestinal tract.
@ast
Survival of anti-Clostridium d ...... human gastrointestinal tract.
@en
prefLabel
Survival of anti-Clostridium d ...... human gastrointestinal tract.
@ast
Survival of anti-Clostridium d ...... human gastrointestinal tract.
@en
P2093
P2860
P356
P1476
Survival of anti-Clostridium d ...... e human gastrointestinal tract
@en
P2093
C Pothoulakis
E F Bostwick
I Castagliuolo
J T LaMont
P2860
P304
P356
10.1128/AAC.41.2.236
P407
P577
1997-02-01T00:00:00Z